Bumrungrad Hospital. Public Company Limited. Investor Presentation. November 2009

Similar documents
Bumrungrad Hospital Public Company Limited

CORPORATE PROFILE.

DBS GROUP HOLDINGS LTD. 15 th Annual General Meeting & Extraordinary General Meeting. 28 April 2014

Fortis to acquire strategic stake in Parkway Holdings, Singapore

2018 1Q IR PRESENTATION

Rovio Entertainment Corporation Annual General Meeting April 9, 2019 CEO REVIEW Kati Levoranta

Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5%

For personal use only

Confirms 2013 Financial Guidance

2Q 2017 Results. 11 Aug 2017 MERMAID MARITIME PUBLIC COMPANY LIMITED

Textron Reports Third Quarter 2014 Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1%

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) 3rd Quarter Report Fiscal year ending March 31, 2018

Results Briefing Fourth Financial Quarter, 2012* Analyst & Investor Update 20 th December 2012

ASX: UCW FULL YEAR RESULTS FOR THE YEAR ENDED 30 JUNE 2017

At the forefront of Abu Dhabi s economic diversification. August 2008

ASX Announcement. 20 November AGM Presentations

Pierre Brondeau Vice President, Business Group Executive Electronic Materials Regional Director - Europe Lehman Brothers Conference Call November

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

First Quarter 2014 Results

KOHLBERG CAPITAL CORPORATION. May 2007

Well-poised to become a dominant real estate player with potentially the largest portfolio of HSR projects

Do Mid-Cap Private Equity Funds Have an Advantage in Today s Markets?

RAZER INC. CORPORATE PRESENTATION

IHH HEALTHCARE BREAKS GROUND FOR GLENEAGLES SHANGHAI AS PART OF RMB8 BILLION PUSH INTO GREATER CHINA

Textron Reports First Quarter 2016 Income from Continuing Operations of $0.55 per Share, up 19.6%; Reaffirms 2016 Financial Outlook

MARKET REPORT. Welcome to UAE The fastest growing healthcare Tourism destination in the world. Arab International Dental Conference & Exhibition

HY2015. Disciplined performance management. Redefining the future for people and places 1. Attractive growth fundamentals & opportunities

IR Presentation. March 2014

1Q 2016 Results. Mermaid Maritime Plc. May 23, 2016

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2016

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018

BAYPORT SECURITISATION (RF) LTD INVESTOR REPORT DECEMBER 2014

Harry J. Cynkus. Senior Vice President, Chief Financial Officer and Treasurer

The partner of choice for self-care products

Table of Contents. 1. 4Q13 Earnings Summary - Financial Highlights. 2. Service & Business Strategy. 3. Mobile 4. PC. 5. Appendix

Abu Dhabi In context. 9% World s Oil. 87% Land Mass. 4% World s Gas 65% UAE GDP. Reserves. Reserves

Harry J. Cynkus. Senior Vice President, Chief Financial Officer and Treasurer

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

G5 Entertainment. Investor Presentation

Textron Reports Third Quarter 2018 Results; Narrows Full-Year EPS and Cash Guidance

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION 2017

G5 Entertainment. Investor Presentation

2017 ANNUAL REPORT. Excellence. Sustained.

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Rod Larson President & CEO

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

Bayport Securitisation (RF) Ltd Investor Report February 2013

Investor Presentation. November 2018

Bayport Securitisation (RF) Ltd Investor Report May 2013

Q Presentation. DOF Subsea Group

Union Properties PJSC

Fourth Quarter 2013 Results. February 6, 2014

Century Properties 2013 revenues reach a record high of P10.8B**

Bringing More to the Table

Redefining the future for people and places 1

Investor Presentation

In the quarter, Textron returned $344 million to shareholders through share repurchases, compared to $186 million in the first quarter of 2017.

Lupin Limited Annual Results FY12. Investor Presentation May being

Sidoti & Company Spring 2017 Convention

Q4 & FY18 PERFORMANCE HIGHLIGHTS JUNE 2018

4 th Quarter Earnings Conference Call

2008 San Francisco Money Show August 7-10, GRAVITY Co., Ltd. (NASDAQ: GRVY)

An Experienced Approach to Private Equity

Helping People Worldwide Build their Financial Security

2Q 2016 Results. Mermaid Maritime Plc. August 2016

Annual results 2005/06

Pareto Securities 20 th Annual Oil & Offshore Conference. Dan Rabun, Chairman & CEO. 4 September 2013

Quarterly presentation Q DOF Subsea Group

KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform. December 2017

MAYBANK INVESTMENT BANK AFFIRMS LEADERSHIP POSITION BY GARNERING SEVERAL MORE PRESTIGIOUS AWARDS

Transition PPT Template. J.P. Morgan. June 2015 V 3.0. Energy Equity Conference June 27, 2017

LUPIN LIMITED Q3FY17 Investor Presentation February 09, 2017

THE STARS GROUP 2017 ANNUAL AND SPECIAL MEETING MANAGEMENT PRESENTATION MAY 10, 2018, TORONTO, 11:30 (ET)

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

China Ophthalmic Hospital Industry Report, May 2013

Agenda Interim Results Highlights. Strengths, Accomplishment & Future. Appendix

Dormitory Authority Finance Committee Meeting December 12, 2017

Goldman Sachs Global Energy Conference. January 2014

Business Plan. Level 8, Admiralty Centre Tower II 18 Harcourt Road Admiralty, HONGKONG

Investcorp growth continues with net income rising to $125 million

Weathering the Storm The Case of Abu Dhabi

Interim Results. IGG Inc August 2018

PERENNIAL REAL ESTATE HOLDINGS LIMITED

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Overview of Strategies and Plans Fiscal Year ending March 31, 2019

ENHANCING OUR GOVERNANCE

MERMAID MARINE AUSTRALIA LTD INVESTOR BRIEFING DEVELOPMENT OF DAMPIER SUPPLY BASE

Capital One Securities, Inc.

Strong Equity Support

SME Internationalization and Measurement (Presentation)

PROPERTIES OF SUCCESS Q2-11 INSTITUTIONAL INVESTOR PRESENTATION

Presentation. March 2007

KKR & Co. L.P. Announces Second Quarter 2014 Results

Overview of Venture Equity

Erratum to the Press Release 2017 annual results - NRJ Group. dated March 15, 2018

Mubadala Development Company PJSC 2010 Full Year Results 24-March-2010

Sonic Expands into USA Pathology Market Acquisition of Interest in CPL

DETAILED FINDINGS VICKERS & BENSON

DANA GAS RELEASES Q1 FINANCIAL RESULTS

2014 Annual Results Presentation 26 March, 2015

Transcription:

Bumrungrad Hospital Public Company Limited Investor Presentation November 2009

Recent Updates Bangkok Facility 7 additional floors (of which 4 are outpatient clinics) of the new BI Clinic Building opened on 30 May 08, resulting in increase in outpatient capacity to 4,500 visits per day Renovation of the inpatient beds in the existing hospital building started in Feb 08; 298 rooms are completed as of Oct 09 Launched Healthy Living Club in mid-june 08 to attract domestic patients; 19,000 members as at Nov 09 International Expansion Asia Renal Care: Successfully acquired 60% (cumulative group holding) of a chain of 14-clinic dialysis operator in Thailand in Feb 09 Number of clinics increased to 105, in 7 Asian countries as at Oct 09 AHI in the Philippines: The expansion plans, including renovation of existing building and construction of a new 14-storey building with additional outpatient & inpatient capacity, are on schedule Bumrungrad International Limited s shareholding in AHI increased to 56.4% from conversion of management fee into equity Bumrungrad International Limited s shares in Bumrungrad Hospital Dubai have been sold back to Istithmar 2

Agendas Introduction to BH BH Financial Performance Bumrungrad International, Bangkok Bumrungrad International Limited Business Strategy 3

Fact Sheet With a 29 year track record, BH is now the leading healthcare service provider in South-East Asian region Established in 1980; listed on SET in 1989 Major operations divided into Bangkok facility and international business Bangkok Facility Facilities One of the largest and most sophisticated private hospitals in South-East Asia 538 inpatient beds and 4,500 outpatient capacity per day Thailand s leading tertiary medical center Accreditation 1 st hospital in Asia to receive US JCI Accreditation 1 st private hospital in Thailand with Thai Hospital Accreditation Patient Volume & Revenue Over one million patients treated annually International following with 420,000 international patients from 190 countries Services 19 specialist departments; 102 sub-specialist departments International Presence Asian Hospital Inc. in the Philippines with 253-bed capacity Bumrungrad Al Mafraq Hospital, a public hospital in Abu Dhabi with 488 beds (management contract) Asia Renal Care with a chain of 105 dialysis clinics in 7 Asian countries Shareholding Structure Others, 51.17% As of Mar 2009 Bangkok Bank Pcl. 1.08% Net Profit Contribution For the year 2008 Bumrungrad International Limited 5.45% Sinsuptawee AM 8.67% Bangkok Insurance Pcl. 13.16% Istithmar 5.94% Temasek 5.94% UOB Kay Hian (HK) Littledown - Client Account Nominees Limited 9 8.04% 6.00% Total Net Profit = THB 1,191 million Bumrungrad International Hospital, Bangkok 94.55% 4

Regional Presence Presence in 8 countries, with 108 clinic and hospital locations Bangkok, Thailand Thailand South Korea 17 Locations 10 Locations 6 Japan 8 2 Locations 2 1 5 Taiwan 3 33 Locations United Arab Emirates Malaysia 7 Philippines 8 Locations 4 Singapore Philippines 22 Locations 13 Locations 5

Group Structure Core business of BH is the renowned Bumrungrad Hospital Bumrungrad Hospital Public Company Limited ( BH ) 100.0% 100.0% 31.5% 100.0% 100.0% 30.0% Bumrungrad Medical Center Ltd. ( BMC ) Vitallife Corporation Ltd. ( Vitallife ) Bumrungrad International Ltd.* Asia Global Health Ltd. ( AGH ) Asia Global Research Co., Ltd. ( AGR ) CDE Trading Co., Ltd. ( CDE ) Owns main hospital building Comprehensive wellness center specializing in preventive care International business Regional healthcare opportunities Clinical research Dormant 56.4% 100.0% Management Contract Asian Hospital Inc. ( AHI ) Asia Renal Care Ltd. ( ARC ) Bumrungrad Al Mafraq Hospital Note: As of Nov 2009 * The strategic partners of Bumrungrad International Limited are: - Istithmar 19.5% - Temasek 19.5% - Asia Financial Holding 19.5% - Bangkok Bank 10.0% 49.0% 51.0% Asia Renal Care (Thailand) Co., Ltd. ( ARC Thailand ) 6

Management Team BH s management team comprises individuals with extensive experience in healthcare management K. Linda Lisahapanya Managing Director Mr. Curtis Schroeder Group CEO Dr. Sinn Anuras Group Medical Director Mr. James Mash CEO Asia Global Research Mr. Dennis Brown CEO Bumrungrad International Ltd. Mr. Mack Banner CEO Bumrungrad International, Bangkok Mr. Anthony Tan CEO Vitallife Corporation Ltd. Mrs. Lee Chan Khor CFO Bumrungrad International, Bangkok Ms. Karen Carter COO Bumrungrad International, Bangkok Ms. Janice Chan CEO Bumrungrad International Holdings (Hong Kong) Limited Mr. John Nickens CEO Bumrungrad Al Mafraq Hospital Abu Dhabi, U.A.E. Mr. Theo Seiler CEO Asian Hospital Inc. Philippines Mr. C.B. Lim CEO Asia Renal Care Limited Singapore Note: As of May 2009 7

Third Party Recognitions: 2008 - A Year of Awards 1. Thailand s Best Small Cap Company 2008 Awarded by Hong Kong-based Asiamoney magazine in January 09, based on survey of investment managers 2. Wall Street Journal Award Recognition Rank No.1 Most Admired Thai Companies Rank no. 4 overall among Thailand s top 10 companies 4. Thailand Tourism Award 2008 Award of Excellence (top prize) 5. Best International Medical Travel Website Washington D.C., 9 December 2008 6. Thailand Most Innovative Company By Chulalongkorn University s school of business 3. Award of Excellence, Outstanding Achievement and Special Recognition in 7. Most Desirable Companies to Work for in Thailand Bumrungrad ranks #7 overall and #1 in healthcare By Business.com Magazine APPLIED MEDICAL INFORMATICS 2008 8. Company with Very Good Corporate Governance Scoring By Thai Institute of Directors Association 9. Thailand Quality Class (TQC) 2008 By Office of Thailand Quality Award 8

Operating Performance 2004-2008 2008 Total Revenue EBITDA Sales (THB mm) 12,000 10,000 8,000 6,000 4,000 2,000 5,809 11% CAGR 6,807 7,896 9,413 829 8,584 8,925 EBITDA (THB mm) 3,000 2,500 2,000 1,500 1,000 500 1,351 12% CAGR 1,664 1,928 2,070 2,155 0 2004 2005 2006 2007 2008 BH reported a one-time gain on share of profit in investment in CDE Trading (Previously GCS Thailand) in 2007 of THB 829 million, mainly from sale of GCS Thailand s assets Source: Audited FS Net Income 0 2004 2005 2006 2007 2008 Source: Audited FS DILUTED EPS Net Income (THB mm) 1,800 1,500 1,200 900 600 300 935 6% CAGR 1,053 1,096 1,605 458 1,147 1,191 Diluted EPS (THB) 2.0 1.5 1.0 0.5 1.01 1.21 8% CAGR 1.26 1.85 0.56 1.29 1.37 0 2004 2005 2006 2007 2008 One-time items of THB458 million in 2007 due share of profit in investment in GCS Thailand, netted off with impairment of software system H2000 Source: Audited FS 0.0 Source: Audited FS 2004 2005 2006 2007 2008 9

9M09 Update Revenue from Hospital Operations EBITDA THB million 8,000 6,000 6,523 3% 6,711 THB million 2,000 1,500 1,648 3% 1,701 4,000 1,000 2,000 500 0 Source: Audited FS 9M08 9M09 0 Source: Audited FS 9M08 9M09 Net Income THB million 1,000 800 899 5% 946 Revenue from hospital operations was up 3% as a result of: Inpatient revenue growth of 3% Outpatient revenue growth of 5% 600 EBITDA increased by 3%, in line with the increase in revenue from hospital operations 400 200 Net income increased by 5% because of lower interest expense and effective tax rate 0 Source: Audited FS 9M08 9M09 10

Margins & Trend Gross Margin Trend EBITDA Margin Trend 45% 30% 40% 35% 35.6% 37.6% 37.6% 38.5% 38.3% 38.7% 25% 23.4% 24.5% 24.5% 24.2% 24.3% 24.6% 30% 20% 25% 20% 2004 2005 2006 2007 2008 9M09 15% 2004 2005 2006 2007 2008 9M09 Net Profit Margin Trend vs. Effective Tax Rate 25% 20% 15% 16.1% 15.5% 13.9% Net Margin (LHS) Effective Tax Rate (RHS) 17.1% 13.3% 13.6% 100% 80% 60% Gross margin and EBITDA margin are on a rising trend over the past 5 years, signifying the efficiency of the operations Net profit margin, however, was more dependent on the effective tax rate 10% 28.5% 27.7% 27.4% 28.6% 5% 17.2% 12.8% 0% 2004 2005 2006 2007* 2008 9M09 * Net margin in 2007 includes one-time non-operating items 40% 20% 0% BH used up all of its tax-loss-carried-forward in 2005 and paid full tax rate in 2006 onwards 11

Leverage Debt to Equity x 1.20 1.03 Interest Coverage x 30.0 28.1 0.90 0.60 0.30 0.68 0.54 0.41 0.39 0.35 20.0 10.0 11.4 15.6 17.7 18.7 18.8 0.00 2004 2005 2006 2007 2008 9M09 0.0 2004 2005 2006 2007 2008 9M09 Net Debt to Equity x 0.50 0.40 0.30 0.37 0.39 0.27 0.28 0.31 0.29 Improvement of the balance sheet over the years, both in terms of D/E and interest coverage as the long-term debt is gradually paid-off Loan was refinanced on 1 Oct 09, with additional 0.20 credit line of THB 1.4 billion, extended repayment 0.10 schedule and lower interest rate 0.00 2004 2005 2006 2007 2008 9M09 12

The Current Economic Environment Healthcare during recessions Our action plans Accelerate refurbishment of existing BI Hospital Building Focus on domestic market Open new international markets Tight cost control: no service effect Conserve & manage cash Continue Bumrungrad International Limited s investments as planned Hold on Dubai Source: McKinsey on Finance, Winter 2009 13

Bumrungrad International Hospital, Bangkok 14

Revenue Breakdown Inpatient vs. Outpatient (% of revenue) Method of Payment (% of revenue) 100% Inpatient Outpatient Insurance 12% Corporate contracts 16% 75% 46% 47% 49% 49% 51% 51% 50% 25% 54% 53% 51% 51% 49% 49% 0% Self-pay 72% 2004 2005 2006 2007 2008 9M09 As of Sept 2009 Revenue contribution from outpatient continues as majority share following worldwide trends towards ambulatory care; BI Clinic well positioned for future growth. Corporate contracts increasing especially from foreign accounts; self-pay remains the primary method of payment. 15

International Patients Growth International in International Revenues Patients THB mn 2,500 THB mn 2,500 International patients remain a solid customer base; BH served approximately 420,000 international patients in 2008 OPD Revenues 2,000 1,500 1,000 500 1,862 1,557 1,620 1,659 1,654 1,314 1,253 2,055 1,915 1,871 2,000 1,500 1,000 500 IPD Revenues Two main sources of international patients: - Domestic expatriate community - Foreign medical tourists Due to the generally high revenue intensity for international patients, foreign patients revenue expanded at a rate of 11% CAGR (5 years) 0 0 2004 2005 2006 2007 2008 9% CAGR IPD OPD 13% CAGR Note: Revenues net of doctors fees Top growing countries are the Middle East and Mongolia, while the US is the most affected by the global economic meltdown & Thailand s political situation. Volume Contribution by Nationality 100% Revenue Contribution by Nationality 100% % of Volume 80% 60% 40% 20% 64% 62% 59% 59% 59% 36% 38% 41% 41% 41% 60% 40% % of Revenue 80% 60% 40% 20% 51% 47% 46% 45% 46% 49% 53% 54% 55% 54% 46% 55% 0% 2004 2005 2006 2007 2008 9M09 0% 2004 2005 2006 2007 2008 9M09 International Thais International Thais 16

Bangkok Facility Expansion Plan Inpatient Capacity - Open Beds Bumrungrad International Bangkok plans to expand and upgrade its facilities over the next 5 years The facilities will give a better overall hospital experience for the patients 700 600 500 400 300 200 BH Tower BI Hospital Building 458 486 486 486 486 486 649 109 540 Renovation + Expansion 100 0 2009 2010E 2011E 2012E 2013E 2014E M ax Capacity Outpatient Visit Capacity per day BI Hospital Building BI Clinic Building BH Tower 6,000 5,000 4,000 4,500 4,800 5,100 5,700 6,000 6,000 3,000 2,000 1,000 Outpatient: 4,500 6,000 visits per day Inpatient: 500 650 beds 0 2009 2010E 2011E 2012E 2013E 2014E Opening of BI Clinic: 21 st Fl Opening of BI Clinic: 19 th & 20 th Fl Opening of BI Clinic: 18 th Fl Opening of BI Clinic: 17 th Fl * BI Clinic Building was opened in mid-2008, resulting in increase in outpatient capacity from 3,500 visits per day to 4,500 visits per day Renovation of BI Hospital Building Women s Center Digestive Disease Center 17

CAPEX Program CAPEX allocated by project Bt million 1,500 1,000 905 1,130 896 1,161 BH Tower BI Hospital Building BI Clinic Building Maintenance 1,038 937 Total CAPEX for the capacity expansion and renovation over the next 5 years (2010-2014): (Excluding Maintenance CAPEX) 500 - New BI Clinic Building Bt 335 million 0 2009A/E 2010E* 2011E 2012E 2013E 2014E - Existing BI Hospital Building Bt 604 million - BH Tower Bt 660 million CAPEX allocated by asset type Bt million 1,500 Construction in Progress Equipment & software Building and Construction Total Bt 1,599 million 1,000 905 1,130 896 1,161 937 1,038 500 0 2009A/E 2010E 2011E 2012E 2013E 2014E 18

An All New Concept BI Clinic Ground Floor Lobby, Parking and 5 floors of clinic space of the new outpatient building are now open Sky Lobby Ground Floor Lobby Welcome Center New Clinics 19

Complete Renovation Existing Inpatient Wards The hospital room of the future today! The rolling renovation of the inpatient wards of existing hospital building started in Feb 2008; and scheduled to be finished by Aug 2010 As of Oct 09, 298 rooms have been renovated 20

Bumrungrad International Limited 21

Bumrungrad International Limited Capital Info Total: THB 3,898 million BBL THB 422 million Asia Financial Holdings THB 823 million Total: THB 3,898 million Working Capital THB 548 million Bumrungrad Hospital Dubai, THB 94 million (USD 2.7 million) Asian Hospital THB 666 million (USD 20 million) Temasek THB 823 million Istithmar THB 823 million Asia Renal Care THB 2,590 million (USD 75 million) BH THB 1,008 million Note: As of December 2008 Capital Injected Investments Remaining commitment by Bumrungrad International Limited s shareholders is THB 450 million, Pro-rated by shareholding percentage (THB 142 million for BH) 22

Bumrungrad International Limited To update Current Portfolio Investments Asian Hospital, Inc. ( AHI ) Asia Renal Care Ltd. ( ARC ) Bumrungrad Al Mafraq Hospital, Abu Dhabi Ownership 56.4%* * Total percentage of ownership 100% Management Contract Partners Other shareholders: Dr. Garcia 8.2% Insular Life 11.8% Filinvest 8.3% Others 15.3% - Contractor: Health Authority of Abu Dhabi Amount & Year invested (by Bumrungrad International Limited) USD 10 million 2005 USD 10 million 2008 USD 75 million 2007 NA 2007 Business 346-bed private hospital Chain of dialysis clinics (105 clinics) 460-bed public hospital 23

Asian Hospital, the Philippines (AHI) 2002: Opened as a 253-bed private hospital, one of the largest in the southern Luzon corridor of metropolitan Manila, the Philippines Feb 2005: Acquired by Bumrungrad International Limited Sept 2009: Bumrungrad International Limited s shareholding in AHI increased from 43% to 56.4% from the conversion of management fees into equity and new capital injection Since the acquisition, the hospital has turned around and started to make profit in 2007 With the hospital operating at almost its full capacity, AHI is undergoing an expansion plan over the next two years to increase the number beds to 346 beds 24

Asia Renal Care Limited (ARC) 1997: Established by reputable financial investors June 2007: Acquired 100% by Bumrungrad International Limited Sept 2009: Headquartered in Singapore and is the leading private provider of dialysis and related services in Asia Operates inpatient and free-standing outpatient dialysis clinics in 7 countries (Singapore, Malaysia, Philippines, Taiwan, South Korea, Japan and Thailand), providing regular treatment to approximately 5,600 patients Holds leading positions in most of the high growth markets it operates, with established platform to further expand into other suitable Asian and Middle Eastern markets Expanded into Thailand in Feb 09 by acquiring Nephromed Group, a chain of 14 dialysis clinics The management plans to aggressively expand the number of clinics over the next three years No of Clinics 120 105 100 82 80 77 67 60 60 49 40 20 0 2004 2005 2006 2007 2008 'Sept 09 25

Bumrungrad Al Mafraq Hospital, Abu Dhabi, U.A.E. Management contract signed with the Health Authority of Abu Dhabi for 4 years, December 2007-2011 In-patient capacity of 460 acute care beds, 28 intensive care and 14 special care baby unit beds Patient volume of ~310,000 patients, including more than 25,000 inpatients annually Simultaneously, a new modern hospital building will be constructed on an adjacent site starting this year that will replace the current facility by mid-2011 26

Bumrungrad International Limited In Summary Bumrungrad International Limited is profitable, with significant improvement in net profit from USD 1.5 million in 2007 to USD 5.5 million in 2008, as the three operating projects in the portfolio are profitable - AHI has become profitable and is generating good internal cash flow - ARC continues to be a stable source of profits - Management fees from Bumrungrad Al Mafraq Hospital is also accretive Expansion plans of the existing projects are now set - Capacity expansion of AHI - Acquisition of clinics by for ARC Bumrungrad International Limited s management continues to pursue additional investment opportunities in the region 27

2009-2010 2010 Strategy: Growth from Insight, Intelligence and Innovation 1. New Patient Experience The renovation and expansion of the Bangkok campus not only adds capacity, but also totally re-invents the way healthcare services are delivered New outpatient clinics are designed to be more patientcentric, serving the often different needs of Thai and international patients New inpatient rooms of the future incorporate the latest of the following: + Bedside medication administration technology + Total communication and entertainment + Environmental control + Patient safety & evidence based design The Result: Bumrungrad is back on top as Asia s premier healthcare facility 28

2009-2010 2010 Strategy: Growth from Insight, Intelligence and Innovation 2. IT Innovation Bumrungrad s 10 year investment in advanced IT has resulted in a clearly differentiated product, improved patient safety and efficiency resulting in some of the industry s highest margins and ROA. As part of its commitment to best practices, Bumrungrad Hospital in Bangkok is the first in Asia to implement a robotic pharmacy dispensing system and automated laboratory system, which will be fully integrated with its IT system. With Microsoft as a strategic alliance partner, Bumrungrad will remain at the world-wide forefront of IT healthcare technology to the benefit of the patients and shareholders. 29

2009-2010 2010 Strategy: Growth from Insight, Intelligence and Innovation 3. Anticipating Long-Term Trends Bumrungrad s vision of the next generation of healthcare IT resulted in the 2007 sale to Microsoft of its software development company and the continued advantages of the strategic alliance. Long before others, Bumrungrad anticipated and exploited the medical tourism opportunity in1997 and is now at the vanguard of the next wave in medical travel: The Global Care Option Bumrungrad International Limited is leveraging Bumrungrad s brand equity to attract world-class investment partners to invest in healthcare opportunities throughout Asia and the Middle East. All of Bumrungrad International Limited s operating investments are profitable and growing. 30